QU╔BEC CITY, Feb. 23 /PRNewswire-FirstCall/ - Ăterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), (the "Company"), a late-stage drug development company specializedin oncology and endocrinology, today announced that its President and CEO, Juergen Engel, Ph.D., will take part in a panel discussion titled, "Cancer: Improving Treatment through Combination Therapy" at the RBC Capital
A live audio webcast of the panel discussion will be available in the Investors section of the Company's website at www.aezsinc.com. A replay of the webcast will also be available on its website for a period of 30 days.
About Ăterna Zentaris Inc.
Ăterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.
Subscribe to our Free Newsletters!
Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...
Abruptio placenta is a serious but rare complication of pregnancy where a separation of placenta ...
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...View All